967 related articles for article (PubMed ID: 9007946)
21. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
22. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of the Rb and p53 pathways in uveal melanoma.
Brantley MA; Harbour JW
Am J Pathol; 2000 Dec; 157(6):1795-801. PubMed ID: 11106551
[TBL] [Abstract][Full Text] [Related]
24. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Heindl LM; Hofmann TN; Knorr HL; Rummelt C; Schrödl F; Schlötzer-Schrehardt U; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383
[TBL] [Abstract][Full Text] [Related]
25. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread?
Heindl LM; Hofmann TN; Schrödl F; Holbach LM; Kruse FE; Cursiefen C
Arch Ophthalmol; 2010 Aug; 128(8):1001-8. PubMed ID: 20697000
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
[TBL] [Abstract][Full Text] [Related]
27. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults.
Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382
[TBL] [Abstract][Full Text] [Related]
28. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis.
McLean IW; Foster WD; Zimmerman LE
Hum Pathol; 1982 Feb; 13(2):123-32. PubMed ID: 7076200
[TBL] [Abstract][Full Text] [Related]
29. Chromosomal abnormalities, p53 and Bcl-2 expression and clinical outcome in choroidal melanoma.
Erol N; Oner U; Artan S; Işiksoy S; Yurdakul S
Melanoma Res; 2004 Dec; 14(6):473-8. PubMed ID: 15577317
[TBL] [Abstract][Full Text] [Related]
30. Multifocal intraocular malignant melanoma: report of two cases and review of the literature.
Dithmar S; Völcker HE; Grossniklaus HE
Ophthalmology; 1999 Jul; 106(7):1345-8. PubMed ID: 10406619
[TBL] [Abstract][Full Text] [Related]
31. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract][Full Text] [Related]
32. p53 Protein expression in nevi and melanomas.
Cristofolini M; Boi S; Girlando S; Zumiani G; Cristofolini P; Dalla Palma P; Doglioni C; Barbareschi M
Arch Dermatol; 1993 Jun; 129(6):739-43. PubMed ID: 8507076
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical detection of the gene p53 and p21 expression in cells of the malignant melanoma of the uvea].
Tokosová E; Hermanová M; Uhmannová R; Smardová J; Hlinomazová Z
Cesk Slov Oftalmol; 2008 Jul; 64(4):153-6. PubMed ID: 18780655
[TBL] [Abstract][Full Text] [Related]
35. p53 expression is rare in cutaneous melanomas.
Saenz-Santamaría MC; McNutt NS; Bogdany JK; Shea CR
Am J Dermatopathol; 1995 Aug; 17(4):344-9. PubMed ID: 8600797
[TBL] [Abstract][Full Text] [Related]
36. Clinical and histopathological features and immunoreactivity of human choroidal and ciliary melanomas as prognostic factors for metastasis and death.
Simões CC; Call MK; Corrêa ZM; Spaulding AG; Augsburger JJ
Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1795-803. PubMed ID: 21847577
[TBL] [Abstract][Full Text] [Related]
37. Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.
Nell RJ; Menger NV; Versluis M; Luyten GPM; Verdijk RM; Madigan MC; Jager MJ; van der Velden PA
BMC Cancer; 2021 Feb; 21(1):164. PubMed ID: 33588787
[TBL] [Abstract][Full Text] [Related]
38. Uveal melanoma and pregnancy. A report of 16 cases.
Shields CL; Shields JA; Eagle RC; De Potter P; Menduke H
Ophthalmology; 1991 Nov; 98(11):1667-73. PubMed ID: 1800927
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
40. Serum adiponectin, insulin resistance, and uveal melanoma: clinicopathological correlations.
Sevim DG; Kiratli H
Melanoma Res; 2016 Apr; 26(2):164-72. PubMed ID: 26630661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
